Biopharma Business

Tag "cancer treatment"

Novartis’ lung cancer drug combination receives EU approval

The European Commission has approved Novartis’ Tafinlar (dabrafenib) in combination with Mekinist (trametinib) for the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer (NSCLC). The

Read Full Article

EMA Recommends Approval of New Treatment for Brain Cancer

Apeiron Biologics has announced that the EMA’s CHMP has recommended the approval of APN311 for immunotherapy of high risk neuroblastoma. Apeiron Biologics is a Vienna-based biotech company developing immunological approaches

Read Full Article

Tumor-targeting system uses cancer’s own mechanisms to betray its location

By hijacking a cancer cell’s own metabolism, researchers have found a way to tag and target elusive cancers with small-molecule sugars. This opens treatment pathways for cancers that are not

Read Full Article

New biomarkers for bowel cancer treatment

One of Europe’s largest collaborative academic-industry research projects, designed to develop and assess novel approaches for identification of new markers for colon cancer, has been conducted by public-private consortium OncoTrack.

Read Full Article

New drug for treatment of aggressive breast cancer found by Irish researchers

As recently published in the International Journal of Cancer, researchers from Breast-Predict, may have found a new drug for the treatment of Triple-negative breast cancer. The drug APR-246, which will

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here